Scientific Advisory Board
We have a strong reputation amongst the research community for having an extensive and robust review process, which takes into account not only the views of world-leading researchers, but also people affected by pancreatic cancer.
Funding decisions are overseen by our Board of Trustees based on the recommendations of our Scientific Advisory Board (SAB), which includes world-leading researchers from around the world. The SAB is responsible for assessing research applications and making recommendations to our Trustees, ensuring that funds raised will be spent as effectively as possible.
Professor Stephen Smith, International Academic and Health Consultancy (previously Dean of the Faculty of Medicine Dentistry and Health Sciences at the University of Melbourne and Chair Melbourne Health Academic Centre)
SAB Vice Chair
Professor James Abbruzzese, Professor of Medicine, Chief of the Division of Medical Oncology and member of the Duke Cancer Institute (DCI), Duke University, USA
A number of distinguished international experts in the field also serve as members of the Board:
- Professor Andrew Biankin, Regius Chair of Surgery/Director of Translational Research Centre, Wolfson Wohl Cancer Research Centre, University of Glasgow, UK
- Professor Eithne Costello, Pancreas Research Group, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, UK
Professor Douglas Fearon, Professor, Cold Spring Harbor Laboratory, USA and University of Cambridge, UK
- Professor Helmut Friess, Department of Surgery, Technische Universität München, Germany
- Professor Nick Lemoine, Director of the Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, University of London, UK
- Professor Gillies McKenna, Head of the Department of Oncology, University of Oxford, UK
- Professor Francisco Real, Programa de Patología Molecular, Centro Nacional de Investigaciones Oncológicas, Madrid, Spain
- Professor Aldo Scarpa, Dipartimento di Patologia, Università di Verona, Verona, Italy
- Doctor Kyoichi Takaori, Graduate School of Medicine, Kyoto University, Kyoto, Japan
- Dr Margaret Tempero, Professor of Medicine, Division of Hematology and Oncology, University of California, San Francisco
- Professor Juan Valle, Professor in Medical Oncology, University of Manchester, UK
SAB lay members
Our SAB currently has two lay members who represent the voice of patients and the public in Pancreatic Cancer UK research funding decisions:
- Roy Bowdery
- Dr Anna Gerring
- Michael Stead
As part of the scientific review process, the Board provides expert advice to the CEO and Trustees on:
- Development of the charity's research strategy and grant giving programme
- External referees for applications ('peer reviewers')
- Assessment of and final recommendations on applications
- Reporting and dissemination of research results.
Conflicts of Interest Policy
The charity has a rigorous policy on conflicts of interest in relation to both external peer reviewers and members of the SAB. Note that an important part of this policy is that the Chair or Vice Chair will withdraw from the entire research grants round if it includes any applications from members of his own research team.